
ENGAGE | CONNECT | LEARN
4.5 hours of CME/CE credits and ABIM and ABPath MOC points for the entire care team
Why Attend?
You'll have the opportunity to participate in multiple activities, including:
- A multidisciplinary interactive tumor board panel ready to lead you through challenging cases
- Breakout sessions that allow for one-on-one time with faculty
- Guidance on patient counseling and shared decision-making
CME Information
Tumor Board with Expert Faculty Panel–90 minutes
Breakout Sessions–90 minutes
- Biomarker Testing: Guidelines and Challenges
- Strategies to Optimize mCRC Treatment Selection
- Patient Counseling
Problem-based Learning Tabletop Exercise of mCRC Patient Cases–60 minutes
Action Plans Development and Summary Report Outs–30 minutes
Why Attend
You'll have the opportunity to paricipate in multiple activities, including:
- A multidisciplinary molecular-based tumor board panel ready to lead you through challenging cases
- Breakout sessions delving into biomarker testing guidelines, challenges, and treatment selection
- Guidance on patient counseling and shared decision-making
CME Information
Tumor Board with Expert Faculty Panel–90 minutes
Breakout Sessions–90 minutes
- Biomarker Testing: Guidelines and Challenges
- Linking Biomarkers to mCRC Treatment Selection
- Patient Counseling
Problem-based Learning Tabletop Exercise of mCRC Patient Cases–60 minutes
Action Plans Development and Summary Report Outs–30 minutes
Faculty Presenters

Tim Cannon, MD
Sheridan Director
Molecular Tumor Board
Co-Director of the Gastrointestinal Cancer Program
Inova Schar Cancer Institute
Fairfax, Virginia

Wei Jiang, MD, PhD
Associate Professor
Director, Translational Research/Pathology Shared Resource of Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania

Benjamin Swanson, MD, PhD
Associate Professor
Associate Director
Gastrointestinal Pathology Fellowship
University of Nebraska Medical Center
Omaha, Nebraska

Frank dela Rama, RN, MS, AOCNS
Clinical Nurse Specialist
Oncology/Genomics
Sutter Health, Palo Alto Foundation
Mountain View, California

Department of Pathology
Ralph E. Lowey Professor of Oncology
George Washington University (GW) School of Medicine and Health Sciences
Washington, D.C.

Manish Shah, MD
Chief, Solid Tumor Oncology
Weill Cornell Medicine
New York, New York

Philip A. Philip, MD, PhD
Professor of Oncology and Pharmacology
Leader, GI & Neuroendocrine Oncology
Medical Director, Cancer Clinical Trials
Chair, GI Cancer, SWOG
Henry Ford Cancer Institute
Wayne State University
Detroit, Michigan
This CME/CE event is presented in collaboration with the following organizations:
